Institute of Science Tokyo (Science Tokyo) launched the Visionary Initiatives (VIs) - a cross-disciplinary, integrated ...

Previously unseen documents show how a poet performed a major ghostwriting job on the autobiography of the two British ...

Gene therapies for rare diseases are frequently developed then discarded by drug companies because they can’t afford to ...

Prime Medicine has had a lot to celebrate in recent months, from positive data to big-name investor interest, explaining a surge that has seen the prime editing therapy developer’s stock more than ...

UC Santa Cruz researchers are sharing examples of how federal funding supports breakthrough innovations in health care.

Researchers from the Department of Biomedical Engineering at UNIST and the Center for Genomic Integrity at the Institute for Basic Science (IBS) have announced an advance in cancer gene therapy. Their ...

Pfizer has agreed to acquire Metsera for up to $7.3 billion, the companies said, in a deal that returns the pharma giant to the obesity and metabolic drug space from which it retreated this past ...

Inherited metabolic diseases are rare monogenic conditions that disrupt biochemical pathways, affecting energy production and ...